Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 39 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Antachopoulos, Charalampos [Clear All Filters]
30th ESPID annual meeting in Thessaloniki, Greece: three decades of ESPID..
Pediatr Infect Dis J. 31(10), 1078-9.
(2012). A 5-year epidemiological study of nosocomial bloodstream infections in a neurosurgery department..
Infect Control Hosp Epidemiol. 31(4), 414-7.
(2010). Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells..
Antimicrob Agents Chemother. 55(5), 1968-74.
(2011). Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa..
Antimicrob Agents Chemother. 59(4), 2198-205.
(2015). Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) due to AIRET16M mutation in a consanguineous Greek girl..
J Pediatr Endocrinol Metab. 24(7-8), 599-601.
(2011).
(2017). Colistin administration to pediatric and neonatal patients..
Eur J Pediatr. 169(7), 867-74.
(2010). Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms..
Antimicrob Agents Chemother. 63(3),
(2019). Drug-resistant tuberculosis in two children in Greece: report of the first extensively drug-resistant case..
Eur J Pediatr. 172(4), 563-7.
(2013). Effects of an Active Surveillance Program and Enhanced Infection Control Measures on Carbapenem-Resistant Gram-Negative Bacterial Carriage and Infections in Pediatric Intensive Care..
Microb Drug Resist. 25(9), 1347-1356.
(2019). Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis..
Pediatr Infect Dis J. 38(1), 42-49.
(2019). Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department..
Transpl Infect Dis. 19(3),
(2017). Epstein-Barr Encephalitis in a Child with Congenital Human Immunodeficiency Virus Infection: A Case Report Calling for No Forgetfulness..
Curr HIV Res. 18(1), 63-66.
(2020). Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area..
J Glob Antimicrob Resist. 20, 214-218.
(2020). Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi..
Mycoses. 53(4), 321-8.
(2010). Immunomodulatory Effects of Colistin on Host Responses against Carbapenem-resistant Klebsiella pneumoniae Biofilms..
Int J Antimicrob Agents. 106182.
(2020). Immunotherapy against invasive mold infections..
Immunotherapy. 4(1), 107-20.
(2012). In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms..
J Antimicrob Chemother. 70(2), 470-8.
(2015). Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism..
Med Mycol. 51(1), 72-82.
(2013). Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria..
J Infect. 77(5), 448-454.
(2018). Isavuconazole: an azole active against mucormycosis..
Lancet Infect Dis. 16(7), 761-762.
(2016). Mannose binding lectin and ficolin-2 polymorphisms are associated with increased risk for bacterial infections in children with B acute lymphoblastic leukemia..
Pediatr Blood Cancer. 61(6), 1017-22.
(2014). Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data..
Eur J Clin Microbiol Infect Dis. 37(7), 1211-1220.
(2018). Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit..
Microb Drug Resist. 25(5), 712-716.
(2019). Nosocomial bloodstream infections in neurosurgery: a 10-year analysis in a center with high antimicrobial drug-resistance prevalence..
Acta Neurochir (Wien). 158(9), 1647-54.
(2016).